Squamous cell carcinoma (SCC) accounts for most malignant oesophageal tumours in China, in contrast to predominance of adenocarcinoma in the Western world.
GENERAL SURGERY
Squamous cell carcinoma (SCC) accounts for most malignant oesophageal tumours in China, in contrast to predominance of adenocarcinoma in the Western world. [1] The outcome for patients with oesophageal SCC continues to be poor, with 5-year survival rates ranging from 26.2% to 49.4% [2] [3] [4] [5] [6] [7] and 10-year survival rates ranging from 8% to 36.1%. [3, 5, 6] However, all these survival rates are estimated ones. Reports of actual 10-year survivors of oesophageal SCC are rare. According to the recent literature, many demographic and clinicopathological factors are associated with survival after surgical resection of oesophageal SCC. However, since long-term survival is unusual, the prevalence of these factors in actual 10-year survivors has not been well documented. The standard factors associated with improved actuarial survival, such as T and N stage, will differ from those associated with actual 10-year survival. We sought to review and describe our two institutions' experience with oesophagectomy for oesophageal SCC in order to identify factors associated with actual, as opposed to actuarial, 10-year survival.
Materials and methods

Study cohort
This retrospective study was approved by the ethics committee of the First Affiliated Hospital of Zhengzhou University and Sun Yat-sen University Cancer Centre, People's Republic of China. The records of all patients who had undergone oesophagectomy for oesophageal SCC at the Cancer Centre were identified. We excluded patients with carcinoma of the cervical oesophagus and gastro-oesophageal junction, and those who underwent surgical exploration without oesophagectomy. We also excluded patients who were still alive but had survived for less than 10 years. Finally, we divided the 1 046 patients we had identified into those who were alive more than 10 years after oesophagectomy and those who had died within 10 years of oesophagectomy.
Surgical procedure
Surgical procedures included primary tumour resection and lymph node dissection. The most commonly used surgical approaches included the left transthoracic procedure, the Ivor-Lewis approach, and the cervico-thoraco-abdominal procedure. The left transthoracic and Ivor-Lewis procedures with anastomosis of the upper chest were performed for all tumours of the lower third of the oesophagus and some tumours of the middle third. The cervico-thoraco-abdominal procedure was used for all tumours of the upper third of the oesophagus and some tumours of the middle third. Extensive lymph node dissection in the posterior mediastinum and abdomen was systematically performed, but cervical lymphadenectomy was not. For patients with cervical anastomosis, the lymph nodes exposed in the cervical incision were dissected. All resected specimens were submitted for pathological examination. A pathological diagnosis was made for primary tumours and lymph nodes, which were separately labelled by the surgeons. The lymph nodes examined included those embedded in the en bloc specimen, which were not labelled but were identified by the pathologists.
Follow-up
A follow-up examination was generally carried out every 3 months in the first year, every 4 months in the second year, and twice a year thereafter. Patients with specific symptoms were examined sooner. Routine follow-up included physical examination, blood biochemical analysis, tumour markers (carcinoembryonic antigen, SCC antigen), a computed tomography scan, oesophagography, ultrasonography and endoscopy. The median duration of follow-up for the patients who were alive was 12 years.
Data retrieved
Patient demographic and clinicopathological characteristics included age, gender, tumour location, severity of dysphagia, weight loss, co-morbidity, a history of smoking and/or alcohol abuse, a family history of any cancer, neo-adjuvant treatment, pathological complete response, surgical approach, completeness of resection, pathological T stage, pathological N stage, histological grade, number of metastatic lymph nodes, number of resected lymph nodes, adjuvant treatment and length of survival. Tumour, node and metastasis descriptors and the staging classification used for this analysis were those defined in the 7th edition of the American Joint Committee on Cancer Staging Manual. [8] 
Statistical analysis
Statistical analysis was done using SPSS version 17.0 (SPSS, Chicago, Illinois, USA) statistical software. Continuous variables were compared using an independent samples t-test. Mean values were described as mean ± standard deviation. Pearson's chisquare test was used to determine the significance of differences between groups for dichotomous variables. Logistic regression was used to compare the 10-year survival group with the non-10-year survival group in order to identify factors associated with long-term survival. A p-value of <0.05 was considered statistically significant. Survival time was measured from the date of surgery to the date of death or last follow-up.
Results
We identified 1 046 patients who had undergone oesophagectomy for SCC. Of these, 84 (8.0%) were actual 10-year survivors. Table  1 sets out their characteristics and those of patients who did not survive for 10 years. Univariate analysis showed that there were significant differences between the two groups with regard to all the variables except neo-adjuvant treatment. Of the entire series, 72 patients (6.9%) underwent neo-adjuvant therapy, and the rate of pathological complete response was 29.2%. Although there was no significant difference between the two groups with regard to the proportion receiving neo-adjuvant therapy, the pathological complete response rate for the 10-year survivor group was higher than that for the group who did not survive for 10 years. There was no patient with co-morbidity, a history of smoking or alcohol abuse, a family history of any cancer or non-R0 resection (R0 resection being defined as resection with negative margins) among the 10-year survivors. Logistic regression analysis showed significant factors associated with actual 10-year survival to be younger age, female gender, absence of dysphagia, a left transthoracic surgical approach, lower pathological T stage, and fewer metastatic lymph nodes (Table 2) .
Discussion
Oesophageal squamous cell carcinoma is associated with short median survival and low cure rates. It is important to understand risk factors in subsets of patients with long-term survival. The standard factors such as T and N stage, which are predictive of [5] and found a 10-year overall survival rate of 8%, a figure consistent with our findings. The independent prognostic factors identified by multivariate analysis were number of metastatic lymph nodes, histological grade, tumour location, depth of invasion and vascular invasion. [5] Chen et al. reported on 1 715 patients with oesophageal SCC who underwent extended oesophagectomy with three-field lymph node dissection. [3] The actuarial 10-year overall survival rate was 36.1%. Univariate and multivariate analyses showed that age of 60 years or more, male gender, tumours more than 5 cm long, poorly differentiated histology, T4 tumours, presence of vascular cancer thrombus in the surgical specimen, lymph node positivity, 3 or more positive lymph nodes, and disease stage II or higher were negative prognostic factors for overall survival. [3] Multivariate analysis of 1 553 patients by Yuequan et al. showed that independent prognostic factors were tumour size, histological grade, pathological stage, and a family history of oesophageal cancer. [2] It has not been determined whether long-term survival in oesophageal SSC is primarily influenced by patient characteristics or tumour biology. Age as a prognostic factor is controversial. [3, 9] We found that there were more younger patients in the 10-year survivor group, and age was identified as a significant factor associated with actual 10-year survival based on logistic regression analysis. However, Turkyilmaz et al. compared survival rates for patients aged 40 years or less and over 40 years, and found that younger patients did not have improved 5-year survival compared with their older counterparts. [9] Many researchers, including ourselves, have demonstrated female gender to be a positive prognostic factor for overall survival, [3, [10] [11] [12] although Cincibuch et al. concluded that female gender was an independent indicator of poor prognosis. [10] However, it should be noted that patients in that study were treated with chemoradiation, not surgery, and patients with adenocarcinoma were included. [10] We found, as have other investigators, [12, 13] that dysphagia was negatively correlated with long-term survival. This is likely to be because dysphagia usually implies relatively late-stage disease. We included pathological T stage [3, 5, 7, 14, 15] and the number of metastatic lymph nodes [2, 3, 5, 14, [16] [17] [18] [19] [20] among the factors that might affect prognosis, as others have confirmed their impact.
Although they were not identified by us as independent predictors of actual 10-year survival, the impact of tumour location, [5, 21, 22] weight loss, [9, 12, 23] completeness of resection [21] and histological grade [2, 3, 5, 20, 22] on prognosis has been proven by other investigators.
We found no patients with co-morbidity, a history of smoking or alcohol abuse, or a family history of any cancer in the 10-year survivor group. Although logistic regression analysis did not identify these as significant factors associated with actual 10-year survival, we considered this an important finding. Other investigators have found these to be negative prognostic factors with regard to overall survival. [2, 13, [24] [25] [26] The left transthoracic surgical approach was identified as a significant factor associated with actual 10-year survival in our study, but other researchers have found that type of oesophagectomy had no prognostic impact. [27] We are unable to explain this finding adequately, although according to traditional practice Chinese surgeons are likely to select that approach in patients with lower-third disease, earlier stage or fewer metastatic lymph nodes. This result was probably impacted on by other relevant factors.
Several researchers found that a higher resected lymph node count favourably influenced survival. [28, 29] We had a counterintuitive result in this regard, with fewer resected lymph nodes in the 10-year survivor group -however, this is not to say that the fewer lymph nodes resected, the better the prognosis. There are two possible explanations for this phenomenon. First, the number of resected lymph nodes in itself had no effect on actual 10-year survival. Other research has also indicated that the number of resected lymph nodes had no prognostic impact. [27] Second, there were relatively more patients with earlier stage and relatively few with enlarged lymph nodes in the 10-year survivor group.
Considerable controversy remains with regard to improved long-term survival associated with neo-adjuvant treatment [12, 27, 30] and adjuvant treatment. [3, 12] Although no significant difference between our two groups was evident when the proportions receiving neo-adjuvant therapy were compared, the pathological complete response rate was higher in the 10-year survivor group than in those with shorter survival. Pathological complete response has been considered a stronger predictor of long-term survival than neo-adjuvant treatment itself. [4, 23, 30, 31] Chen et al. found that postoperative radiation therapy improved overall survival for patients with poor disease-related prognostic factors (positive nodal disease, three or more positive lymph nodes, stage III/IV disease, and large or deeply invasive tumour). [3] However, adjuvant treatment failed to predict long-term survival in our research.
The limitations of the current study included its retrospective format, which meant that comparison between 10-year survivors and those who did not survive for 10 years was subject to selection bias. In addition, the study spanned many years and therapeutic modalities have evolved over time, with increasing use of neoadjuvant and adjuvant treatment. Owing to lack of detailed data on pathological characteristics, we also could not investigate the impact of vascular, perineural and extracapsular invasion on prognosis. Finally, the study excluded patients who underwent oesophagectomy after April 2001 and were still alive, because they had survived for less than 10 years.
In conclusion, the independent positive predictors of actual 10-year survival were younger age, female gender, absence of dysphagia, lower pathological T stage and fewer metastatic lymph nodes.
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